Inventor · disambiguated record
Alazar N. Ghebremeskel
Also filed as: GHEBREMESKEL ALAZAR · GHEBREMESKEL ALAZAR N
16 granted patents·19 pending applications·126 citations·filing 2008–2024
93Inventor score
Top patents by PatentIndex Score
35 records- 0197US8647659B2Intracameral sustained release therapeutic agent implantsROBINSON MICHAEL R·Filed 2011·Granted Feb 11, 2014·46 cites·5 claims
- 0294US10278919B2Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2016·Granted May 7, 2019·10 cites·13 claims
- 0394US9522113B2Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofALLERGAN INC·Filed 2015·Granted Dec 20, 2016·10 cites·4 claims
- 0493US9504696B2Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2015·Granted Nov 29, 2016·8 cites·14 claims
- 0593US9061065B2Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2013·Granted Jun 23, 2015·15 cites·6 claims
- 0692US9492316B2Prostamide-containing intraocular implants and methods of use thereofALLERGAN INC·Filed 2014·Granted Nov 15, 2016·12 cites·18 claims
- 0790US9980974B2Prostamide-containing intraocular implants and methods of use thereofALLERGAN INC·Filed 2016·Granted May 29, 2018·6 cites·7 claims
- 0890US9095506B2Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofSPADA LON T·Filed 2008·Granted Aug 4, 2015·10 cites·2 claims
- 0988US10842739B2Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofALLERGAN INC·Filed 2019·Granted Nov 24, 2020·1 cites·4 claims
- 1087US2024148643A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2023·Application pending·0 cites
- 1186US2025000695A1Intraocular implant with high loading of a prostamideALLERGAN INC·Filed 2024·Application pending·0 cites
- 1286US2024108635A1Prostamide-containing intraocular implants and methods of use thereofALLERGAN INC·Filed 2023·Application pending·0 cites
- 1382US2023285279A1Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofALLERGAN INC·Filed 2022·Application pending·0 cites
- 1480US10471004B2Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofALLERGAN INC·Filed 2018·Granted Nov 12, 2019·1 cites·5 claims
- 1579US2020121593A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2019·Application pending·0 cites
- 1678US9861576B2Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofALLERGAN INC·Filed 2016·Granted Jan 9, 2018·1 cites·5 claims
- 1777US8771745B2Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereofROBINSON MICHAEL R·Filed 2012·Granted Jul 8, 2014·2 cites·1 claims
- 1877US2022218721A1Prostamide-containing intraocular implants and methods of use thereofALLERGAN INC·Filed 2021·Application pending·0 cites
- 1976US12004995B2Intraocular implant with high loading of a prostamideALLERGAN INC·Filed 2021·Granted Jun 11, 2024·0 cites·6 claims
- 2076US2025049994A1Polymer system for securing implants in syringe needlesALLERGAN INC·Filed 2024·Application pending·0 cites
- 2175US2021169780A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2020·Application pending·0 cites
- 2275US2021161809A1Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereofALLERGAN INC·Filed 2020·Application pending·0 cites
- 2373US8715713B2Solvent cast film sustained release latanoprost implantGHEBREMESKEL ALAZAR N·Filed 2012·Granted May 6, 2014·3 cites·4 claims
- 2471US9161929B2Solvent cast film sustained release latanoprost implantALLERGAN INC·Filed 2014·Granted Oct 20, 2015·1 cites·7 claims
- 2571US2022008628A1Polymer system for securing implants in syringe needlesALLERGAN INC·Filed 2021·Application pending·0 cites
- 2669US2019254965A1Intracameral sustained release therapeutic agent implantsALLERGAN INC·Filed 2019·Application pending·0 cites
- 2766US2021030766A1Prostamide-containing intraocular implants and methods of use thereofGHEBREMESKEL ALAZAR N·Filed 2020·Application pending·0 cites
- 2865US10463772B2Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereofALLERGAN INC·Filed 2014·Granted Nov 5, 2019·0 cites·8 claims
- 2965US2018271878A1Prostamide-containing intraocular implants and methods of use thereofALLERGAN INC·Filed 2018·Application pending·0 cites
- 3065US2010104654A1Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereofALLERGAN INC·Filed 2008·Application pending·0 cites
- 3164US2020069847A1Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereofALLERGAN INC·Filed 2019·Application pending·0 cites
- 3260US2015080845A1Polymer system for securing implants in syringe needlesALLERGAN INC·Filed 2014·Application pending·0 cites
- 3350US2023011907A1Methods and apparatus for delivery of ocular implantsALLERGAN INC·Filed 2022·Application pending·0 cites
- 3449US2024024159A1Posterior chamber placement of sustained release implantALLERGAN INC·Filed 2021·Application pending·0 cites
- 3539US2012245505A1Intracameral devices for sustained deliveryROBINSON MICHAEL R·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →